Actively Recruiting
Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients
Led by Tianjin Medical University General Hospital · Updated on 2024-09-04
400
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies
CONDITIONS
Official Title
Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20-65 years old
- ASA classification grade I to III
- Scheduled for elective surgery
- Body mass index between 19 and 30 kg/m2
- Voluntary agreement to participate in the study
You will not qualify if you...
- Allergy to any drug ingredients used in the study or allergic constitution
- History of allergy to general anesthesia drugs, opioid drugs, or non-steroidal drugs
- History of neurological diseases or chronic pain
- Drug or alcohol addiction, long-term opioid use, or opioid use within 48 hours before surgery
- ASA classification grade IV or V
- Coronary heart disease, bronchial asthma, severe hypertension, severe blood disorders, liver or kidney dysfunction, or electrolyte imbalances
- History of gastrointestinal diseases such as peptic ulcer, Crohn's disease, or ulcerative colitis
- Respiratory insufficiency or respiratory failure
- Refusal to use intravenous patient-controlled analgesia (PCA)
- Pregnant or breastfeeding women
- Body mass index less than 18 kg/m2 or greater than 30 kg/m2
- Poor compliance or inability to complete the study procedures
- Participation in other clinical drug trials within the last 4 weeks
- Any condition the researcher considers unsuitable for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University General Hospital
Tianjin, China, 300052
Actively Recruiting
Research Team
G
Guolin Wang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here